Abstract
To estimate the relative risk of invasive cervical cancer in each succeeding year after a negative screening result the screening records of all women tested in the north east of Scotland were examined as the basis for a case-control study. The cases consisted of 115 women in whom invasive cervical cancer had been diagnosed in 1968-82 and who had appeared in the screening records at least once before diagnosis. For each patient five controls were selected from women of the same age who appeared in the screening records before the date of diagnosis in the patient. If the patient's cancer had been detected by screening the controls were chosen from women of the same age screened the same year. A comparison was made between cases and controls of the number of negative smears taken before the diagnosis. The results showed a high relative protection (inverse of the relative risk) in the first two years after a negative test, falling steadily as time since the last negative test elapsed. Even after 10 years, however, a considerable residual effect was observed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aristizabal N., Cuello C., Correa P., Collazos T., Haenszel W. The impact of vaginal cytology on cervical cancer risks in Cali, Colombia. Int J Cancer. 1984 Jul 15;34(1):5–9. doi: 10.1002/ijc.2910340103. [DOI] [PubMed] [Google Scholar]
- Boyes D. A., Morrison B., Knox E. G., Draper G. J., Miller A. B. A cohort study of cervical cancer screening in British Columbia. Clin Invest Med. 1982;5(1):1–29. [PubMed] [Google Scholar]
- Clarke E. A., Anderson T. W. Does screening by "Pap" smears help prevent cervical cancer? A case-control study. Lancet. 1979 Jul 7;2(8132):1–4. doi: 10.1016/s0140-6736(79)90172-7. [DOI] [PubMed] [Google Scholar]
- Day N. E., Walter S. D. Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics. 1984 Mar;40(1):1–14. [PubMed] [Google Scholar]
- Knox E. G. Ages and frequencies for cervical cancer screening. Br J Cancer. 1976 Oct;34(4):444–452. doi: 10.1038/bjc.1976.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- La Vecchia C., Franceschi S., Decarli A., Fasoli M., Gentile A., Tognoni G. "Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet. 1984 Oct 6;2(8406):779–782. doi: 10.1016/s0140-6736(84)90705-0. [DOI] [PubMed] [Google Scholar]
- Macgregor J. E., Teper S. Mortality from carcinoma of cervix uteri in Britain. Lancet. 1978 Oct 7;2(8093):774–776. doi: 10.1016/s0140-6736(78)92658-2. [DOI] [PubMed] [Google Scholar]
- Morrison A. S. Case definition in case-control studies of the efficacy of screening. Am J Epidemiol. 1982 Jan;115(1):6–8. doi: 10.1093/oxfordjournals.aje.a113280. [DOI] [PubMed] [Google Scholar]
- Parkin D. M., Collins W., Clayden A. D. Cervical cytology screening in two Yorkshire areas: pattern of service. Public Health. 1981 Nov;95(6):311–321. doi: 10.1016/s0033-3506(81)80003-0. [DOI] [PubMed] [Google Scholar]
- Raymond L., Obradovic M., Riotton G. Une étude cas-témoins pour l'évaluation du dépistage cytologique du cancer du col utérin. Rev Epidemiol Sante Publique. 1984;32(1):10–15. [PubMed] [Google Scholar]
- Walter S. D., Day N. E. Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol. 1983 Dec;118(6):865–886. doi: 10.1093/oxfordjournals.aje.a113705. [DOI] [PubMed] [Google Scholar]
- Weiss N. S. Control definition in case-control studies of the efficacy of screening and diagnostic testing. Am J Epidemiol. 1983 Oct;118(4):457–460. doi: 10.1093/oxfordjournals.aje.a113650. [DOI] [PubMed] [Google Scholar]